These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17915573)
1. Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle. Vorgerd M; Zange J Acta Myol; 2007 Jul; 26(1):61-3. PubMed ID: 17915573 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Quinlivan R; Martinuzzi A; Schoser B Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD003458. PubMed ID: 25391139 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Quinlivan R; Martinuzzi A; Schoser B Cochrane Database Syst Rev; 2010 Dec; (12):CD003458. PubMed ID: 21154353 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V). Quinlivan R; Beynon RJ Cochrane Database Syst Rev; 2004; (3):CD003458. PubMed ID: 15266486 [TBL] [Abstract][Full Text] [Related]
6. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Vorgerd M; Grehl T; Jager M; Muller K; Freitag G; Patzold T; Bruns N; Fabian K; Tegenthoff M; Mortier W; Luttmann A; Zange J; Malin JP Arch Neurol; 2000 Jul; 57(7):956-63. PubMed ID: 10891977 [TBL] [Abstract][Full Text] [Related]
7. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Vorgerd M; Zange J; Kley R; Grehl T; Hüsing A; Jäger M; Müller K; Schröder R; Mortier W; Fabian K; Malin JP; Luttmann A Arch Neurol; 2002 Jan; 59(1):97-101. PubMed ID: 11790236 [TBL] [Abstract][Full Text] [Related]
8. Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study. Jensen KE; Jakobsen J; Thomsen C; Henriksen O Acta Neurol Scand; 1990 Jun; 81(6):499-503. PubMed ID: 2220306 [TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study. Phoenix J; Hopkins P; Bartram C; Beynon RJ; Quinlivan RC; Edwards RH Neuromuscul Disord; 1998 May; 8(3-4):210-2. PubMed ID: 9631404 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Quinlivan R; Beynon RJ; Martinuzzi A Cochrane Database Syst Rev; 2008 Apr; (2):CD003458. PubMed ID: 18425888 [TBL] [Abstract][Full Text] [Related]
11. Titrating a modified ketogenic diet for patients with McArdle disease: A pilot study. Løkken N; Hansen KK; Storgaard JH; Ørngreen MC; Quinlivan R; Vissing J J Inherit Metab Dis; 2020 Jul; 43(4):778-786. PubMed ID: 32060930 [TBL] [Abstract][Full Text] [Related]
12. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion. Lewis SF; Haller RG; Cook JD; Nunnally RL J Appl Physiol (1985); 1985 Dec; 59(6):1991-4. PubMed ID: 3865926 [TBL] [Abstract][Full Text] [Related]
13. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Kornblum C; Schröder R; Müller K; Vorgerd M; Eggers J; Bogdanow M; Papassotiropoulos A; Fabian K; Klockgether T; Zange J Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248 [TBL] [Abstract][Full Text] [Related]
14. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study. Zange J; Grehl T; Disselhorst-Klug C; Rau G; Müller K; Schröder R; Tegenthoff M; Malin JP; Vorgerd M Muscle Nerve; 2003 Jun; 27(6):728-36. PubMed ID: 12766985 [TBL] [Abstract][Full Text] [Related]
15. Decreased insulin action in skeletal muscle from patients with McArdle's disease. Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial. Hayashi AP; Solis MY; Sapienza MT; Otaduy MC; de Sá Pinto AL; Silva CA; Sallum AM; Pereira RM; Gualano B Lupus; 2014 Dec; 23(14):1500-11. PubMed ID: 25135060 [TBL] [Abstract][Full Text] [Related]
17. Can a modified ketogenic diet be a nutritional strategy for patients with McArdle disease? Results from a randomized, single-blind, placebo-controlled, cross-over study. Løkken N; Nielsen MR; Stemmerik MG; Ellerton C; Revsbech KL; Macrae M; Slipsager A; Krett B; Beha GH; Emanuelsson F; van Hall G; Quinlivan R; Vissing J Clin Nutr; 2023 Nov; 42(11):2124-2137. PubMed ID: 37769369 [TBL] [Abstract][Full Text] [Related]
18. [McArdle's disease. Apropos of a case]. Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954 [TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Experiences with a Low-Carbohydrate Ketogenic Diet: An International Survey in Patients with McArdle Disease. Løkken N; Voermans NC; Andersen LK; Karazi W; Reason SL; Zweers H; Wilms G; Santalla A; Susanibar E; Lucia A; Vissing J Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839201 [TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. Lewis SF; Haller RG J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]